Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute lymphobl
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue), fluorine (light green).
Size: 8000px × 6000px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: None
Keywords: acute, atomic, atoms, bcr-abl, carbon, chemical, chemistry, chromosome, chronic, composition, disease, drug, fluorine, generic, hydrogen, inhibitor, kinase, leukemia, lymphoblastic, medicinal, medicine, model, molecular, molecule, mutation, myeloid, nitrogen, oxygen, pharma, pharmaceutical, pharmacology, pharmacy, philadelphia, ponatinib, ponatinibe, product, therapy, treatment, tyrosine
